INTA vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

INTA

31.6
AI Score
VS
DBD Wins

DBD

47.7
AI Score

Investment Advisor Scores

INTA

32score
Recommendation
SELL

DBD

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric INTA DBD Winner
Forward P/E 26.1097 12.1655 DBD
PEG Ratio 0.7455 0 Tie
Revenue Growth 13.0% 1.7% INTA
Earnings Growth 0.0% 34.2% DBD
Tradestie Score 31.6/100 47.7/100 DBD
Profit Margin -7.1% 2.9% DBD
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD DBD

Relative Price Performance (Last 90 Days)

INTA 1M: -5.8% · 3M: +60.5% DBD 1M: -8.6% · 3M: -19.6%

Current Technical Phase

INTA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.9 · Price: $37.23

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.1%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $65.62

Fundamentals Snapshot

Metric INTA DBD
Market Cap
Forward P/E 24.1 9.4
Trailing P/E 22.1
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.3%
Operating Margin 0.0% 0.1%
EPS -0.51 2.96
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.